Dexmedetomidine for Catheter-related Bladder Discomfort

Phase

Condition

Colic

Pain

Lactose Intolerance

Treatment

N/A

Clinical Study ID

NCT01991223

CRBD_DEX_PHPKHC

CRBD_SNUH1

Ages 19-80
All Genders

Study Summary

To evaluate the efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort

Eligibility Criteria

Inclusion

Inclusion Criteria:

Patients scheduled for transurethral bladder resection
ASA I-III

Exclusion

Exclusion Criteria:

Patient who disagrees to participate this investigation
Patient with severe cardiovascular disease
Patient with small-sized foley catheter (less than 18 Fr.)
Patinets with any urinary tract obstructions
Patient with hyperactive or neurogenic bladder
Patients with chronic renal failure
Patient with morbidly obese
Patients with neurogenic disorder
Patient with medications for chronic pain

Study Design

November 01, 2013

November 30, 2014

Study Description

After transurethral bladder resection, large-sized foley catheter have been used for drainage of urine and residual blood. Because of urinary catheterization, patients usually experiences catheter-related bladder discomfort defined as a burning sensation with an urge to void or discomfort in the supra-pubic region caused by catheter- related bladder irritation.

Dexmedetomidine is an alpha-2 antagonist and used as an analgesic agent. The investigators try to evaluate The efficacy of dexmedetomidine for the treatment of catheter-related bladder discomfort

Connect with a study center

Seoul National University Hospital
Seoul,
Korea, Republic of
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.